United Nations High-level Panel on Access to Medicines
GPTKB entity
Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_Nations_General_Assembly
|
| gptkbp:chairman |
gptkb:Festus_Mogae
gptkb:Ruth_Dreifuss |
| gptkbp:establishedBy |
gptkb:United_Nations_Secretary-General
|
| gptkbp:establishedIn |
2016
|
| gptkbp:focus |
human rights
innovation trade access to medicines |
| https://www.w3.org/2000/01/rdf-schema#label |
United Nations High-level Panel on Access to Medicines
|
| gptkbp:mandate |
address policy incoherence between international human rights, trade rules, and public health objectives
|
| gptkbp:producedDocument |
Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines
|
| gptkbp:publicationYear |
2016
|
| gptkbp:recommendation |
encourage delinkage of R&D costs from medicine prices
improve access to health technologies promote transparency in medicine pricing reform intellectual property rules for public health |
| gptkbp:website |
https://www.unsgaccessmeds.org/
|
| gptkbp:bfsParent |
gptkb:Keizo_Takemi
|
| gptkbp:bfsLayer |
6
|